The rise of Viagra and its effect on the drug landscape presents a complex question for traders. While the first sales statistics were impressive, the patent has ended, leading to a deluge of generic alternatives that are chipping away at profit. Moreover, the industry is facing challenges related to population trends and evolving healthcare guidel